Introducing Menopause Hormone Therapy
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
US Name:
Toujeo
Alternative Names:
Toujeo Solostar
Active Ingredients:
Insulin Glargine
Brand Manufacturer:
Sanofi
Manufacturer Location:
Click here to view Product Insert
Click here to view Product Insert
For visual reference only; actual product may vary
Toujeo (insulin glargine) is a long-acting injectable insulin for managing blood sugar in adults and children six and older. This pre-filled SoloStar pen provides a steady, once-daily dose. Toujeo is a cold-chain product that requires special shipping.
| Toujeo (1.5mL) Brand | 300IU/mL 3 Pre-Filled Pen |
-
|
Our price: $85.00 |
|
| Toujeo (3mL) Brand | 300IU/mL 3 Pre-Filled Pen |
-
|
Our price: $150.00 |
Toujeo is a long-acting, man-made insulin used to control high blood sugar in adults and children with diabetes. Its active ingredient is insulin glargine. This medication helps manage both type 1 and type 2 diabetes. It provides a slow, steady release of insulin into the body. This helps keep blood glucose levels stable over a 24-hour period. Toujeo is not used to treat diabetic ketoacidosis.
Toujeo works by replacing the insulin that your body cannot produce sufficiently. It functions as a basal, or background, insulin. After injection, it forms a depot under the skin. From this depot, small amounts of insulin are slowly released into your bloodstream throughout the day. This action helps move sugar from the blood into other body tissues. The tissues then use the sugar for energy. This constant insulin supply mimics the body’s natural insulin production. It helps prevent dangerous spikes or drops in blood sugar levels.
Toujeo is prescribed for adults and children aged six years and older with type 1 or type 2 diabetes. It is suitable for patients who require a long-acting insulin to maintain stable blood sugar. This includes individuals newly diagnosed with diabetes. It also includes those switching from another insulin treatment. Your doctor will determine if Toujeo is the right choice for your specific condition. The decision depends on your health, lifestyle, and glucose management needs.
Toujeo is administered once daily via a subcutaneous injection, which is an injection under the skin. It should be taken at the same time each day. Your doctor will determine the correct dose for you. The Toujeo SoloStar pen allows for doses from 1 to 80 units per injection. Common injection sites include the abdomen, thighs, or upper arms. You should rotate injection sites with each dose. This helps prevent skin problems like lumps or pitting. Never share your Toujeo pen with others. Always use a new needle for each injection.
Toujeo may cause side effects, though not everyone experiences them. The most common side effect is hypoglycemia, or low blood sugar. It is important to know the signs of low blood sugar. These include shakiness, sweating, and rapid heartbeat. Other potential side effects can occur.
Consult your healthcare provider if you experience any persistent or bothersome side effects. This is not a full list of possible adverse effects.
IsraelPharm offers a reliable and convenient way to purchase your essential medications like Toujeo. We source our products from trusted manufacturers, ensuring you receive authentic and safe medicine. Our prices are competitive, helping you save money on your long-term treatment costs. Our streamlined online ordering process is simple and secure. We provide excellent customer service to assist you with any questions. When you order from us, your medication is shipped directly to your door. This makes managing your diabetes treatment easier than ever before.
The most common adverse reaction with Toujeo is hypoglycemia (low blood sugar). Other potential side effects include:
This is not a complete list. Always read the patient information leaflet and consult a doctor about potential side effects.
Toujeo is an insulin medication used to manage blood sugar levels in patients with diabetes mellitus.
Toujeo contains the same active ingredient as Lantus, insulin glargine, but it is three times more concentrated. This design provides a slower, more gradual release of insulin into the bloodstream. This may lead to more stable blood sugar levels and a lower risk of hypoglycemia (low blood sugar) for some patients. Your doctor can determine which of these long-acting insulins is the better choice for your specific diabetes management plan.
Toujeo should be injected once daily, and it is crucial to take it at the same time every day. This consistency helps maintain stable insulin levels in your body for a full 24 hours. You and your doctor can decide on the best time that fits your personal schedule. Whether you choose morning or evening, sticking to that time is key for effective blood sugar control and management.
A Toujeo SoloStar pen must be discarded 42 days (6 weeks) after you first use it, even if insulin remains. It is important to write the date of first use on the pen label. After this period, the insulin may not be as effective, which could lead to high blood sugar levels. Always dispose of used pens and needles safely as instructed by your pharmacist.
You must never reuse or share needles when using a Toujeo pen for your injections. A new, sterile needle is required for each dose to prevent infection and ensure you receive the correct amount of insulin. Reusing needles can also cause them to become dull, making injections more painful and potentially damaging your skin. Always dispose of needles safely in a sharps container after one use.
If you miss a dose of Toujeo, it is important to contact your doctor or pharmacist for specific instructions. Do not inject a double dose to make up for the one you missed, as this could cause dangerously low blood sugar. Your healthcare provider will advise you on how to adjust your insulin schedule safely to get back on track with your diabetes treatment plan.
Unopened Toujeo pens should be stored in a refrigerator between 36°F and 46°F (2°C and 8°C). Once you start using a pen, you can keep it at room temperature, below 86°F (30°C), for up to 6 weeks. Do not freeze Toujeo, and keep it away from direct heat and light. Proper storage is essential to ensure the insulin remains effective and safe to use.
Toujeo may cause weight gain, which is a common side effect associated with many insulin therapies. This happens because insulin helps your body use sugar more efficiently, and excess sugar can be stored as fat. If you are concerned about gaining weight while using this medication, speak with your doctor. They can provide guidance on diet and exercise to help manage your weight effectively while controlling your diabetes.
Toujeo can interact with alcohol, which may significantly affect your blood sugar levels, often increasing the risk of hypoglycemia. It is very important to talk with your doctor about your alcohol consumption. They can provide personalized advice based on your health. If you do drink, your doctor may recommend limiting your intake and monitoring your glucose levels more closely than usual to stay safe.
Toujeo can cause hypoglycemia, which is the medical term for low blood sugar. Symptoms include feeling shaky, dizzy, anxious, sweaty, or confused. To treat it, you should consume 15-20 grams of a fast-acting carbohydrate. Good sources include glucose tablets, fruit juice, or hard candy. It is important to always carry a source of sugar with you in case your blood sugar drops too low while using insulin.
Toujeo should be injected into the fatty tissue just under the skin of your abdomen, thigh, or upper arm. To prevent skin problems like lumps or pits, it is critical to rotate your injection sites. Avoid injecting into the exact same spot each time. For example, you can use a different part of your abdomen or switch between your right and left thigh for each daily dose.
Toujeo is not a fast-acting insulin and should not be used for rapid correction of high blood sugar. It is a long-acting, or basal, insulin. This means it works slowly over a 24-hour period to provide a steady, background level of insulin in your body. Mealtime insulins are fast-acting and are used to cover the sugar from food, but Toujeo provides a constant foundation of control.
Toujeo is approved by the FDA for use in children who are six years of age and older with either type 1 or type 2 diabetes. The safety and effectiveness in children younger than six have not been established. A pediatric endocrinologist will determine if Toujeo is the right long-acting insulin for a child and will prescribe the appropriate dose to manage their blood sugar levels.
Toujeo solution should always be clear and colorless. Before each injection, you should visually inspect the insulin in the pen. Do not use the medication if it appears cloudy, discolored, or has any particles or clumps floating in it. Using insulin that has gone bad can be dangerous and may lead to poor blood sugar control. Discard the pen if the insulin looks unusual.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name

You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and

People whose weight is higher than what is considered healthy for their height are described as having excessive body mass, clinically defined as being overweight or obese. Both of these can increase a person’s risk


